Over the last years, following and thanks to the genetic discoveries in the MAPT gene, striking observations in patients but mainly in experimental models have changed some long-established convictions concerning the role of protein Tau in cognitive disorders and neurodegeneration. This evidence concerns the gene MAPT and cognitive disorder.